Pangaea Ventures announces participation in Membrion’s $20 Million Series B1

Pangaea Ventures is pleased to announce our participation in Membrion’s $20 Million Series B1 funding, alongside PureTerra, Lam Research, Ecolab, W.L. Gore & Associates., and other existing investors. 

Our investment in Membrion represents a convergence of advanced materials science, technical rigor, impact-driven innovation, and accelerating customer interest, the hallmarks of the companies we champion to drive planetary health. 

“Pangaea has closely followed Membrion’s progress for several years,” shared Pangaea Partner, Sarah Applebaum. “The company is at an exciting commercial inflection point, as the market is waking up to the value that technologies like Membrion can bring to industrial customers, not just in cost savings, but in meaningful operational gains. With each deployment, Membrion reduces water consumption, chemical waste, and energy use while delivering tangible ROI for their customers.”

For more on Membrion, read the full release on their website, here.

Stay tuned to the Pangaea blog for a full breakdown of why we invested in Membrion on October 8th.